Is this you?
Sign in with ORCID to claim this profile — instantly verify it's yours, curate your publications, and take control of how your work appears here.
Is this you?
Sign in with ORCID to claim this profile — instantly verify it's yours, curate your publications, and take control of how your work appears here.
Song Cao's research primarily focuses on cancer genomics and diagnostics, particularly through proteogenomic characterization of various cancers such as breast cancer, lung adenocarcinoma, renal cell carcinoma, glioblastoma, pancreatic ductal adenocarcinoma, and endometrial carcinoma. Publicly indexed outputs suggest a strong emphasis on understanding somatic mutations, signaling pathways, and therapeutic vulnerabilities in these diseases, with additional interests in RNA modifications and protein degradation mechanisms. With an h-index of 45 and a career spanning from 2001 to 2025, Cao's work has garnered significant attention, evidenced by over 34,000 total citations across their indexed publications. Their collaboration network is extensive, involving 573 distinct co-authors. This sustained output and broad collaborative reach highlight a substantial and impactful contribution to the field of cancer research.
Lijun Yao, Julia T Wang, Reyka G Jayasinghe, Julie O'Neal, Chia-Feng Tsai, Michael P Rettig, Yizhe Song, Ruiyang Liu, Yanyan Zhao, Omar M Ibrahim, Mark A Fiala, Julie M Fortier, Siqi Chen, Leah Gehrs, Fernanda Martins Rodrigues, Michael C Wendl, Daniel Kohnen, Andrew Shinkle, Song Cao, Steven M Foltz, Daniel Cui Zhou, Erik Storrs, Matthew A Wyczalkowski, Smrithi Mani, Scott R Goldsmith, Ying Zhu, Mark Hamilton, Tao Liu, Feng Chen, Ravi Vij, Li Ding, John F DiPersio
0 publications
0 other materials
No GitHub profile linked
Alpha1 Science activity will appear here once this profile is claimed.